Another Sleep Apnea Drug May Be on the Horizon for a Broader Population

(MedPage Today) — CHICAGO — A novel combination drug targeting neuromuscular dysfunction in obstructive sleep apnea (OSA) reduced severity of the condition in two pivotal randomized trials.
In the SynAIRgy trial, those who received at least…

Source link : https://www.medpagetoday.com/meetingcoverage/chest/118100

Author :

Publish date : 2025-10-23 14:38:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Another Sleep Apnea Drug May Be on the Horizon for a Broader Population

Ex-Olympian Susan Egelstaff says councils should not cut physical activity

Combo Decolonization Strategy Doesn’t Tame Recurrent Staph Infections in Households

Related Posts

Some Patients Can Maintain Health Gains After Reducing GLP-1 Dose Frequency

Medicare to Cover Blockbuster Obesity Drugs

Inside Epic’s Rapid-Fire Research Machine

Here’s What Blood Cancer Patients Prioritize When Considering Hospice Care

Digital map lets you explore the Roman Empire’s vast road network

Radioactive Shrimp, Ozempic Allegations: The MedPage Today Culture Awards

Some Patients Can Maintain Health Gains After Reducing GLP-1 Dose Frequency

Medicare to Cover Blockbuster Obesity Drugs

Inside Epic’s Rapid-Fire Research Machine

Here’s What Blood Cancer Patients Prioritize When Considering Hospice Care

Digital map lets you explore the Roman Empire’s vast road network

Radioactive Shrimp, Ozempic Allegations: The MedPage Today Culture Awards

Doc Accused of ‘Extreme Rudeness’; Nurse’s Life Sentence; Doc’s $141M Settlement

Belfast woman who ‘strung along’ man over kidney donation is sentenced

Categories

Archives